ANGEL: Threshold VC’s Emily Melton on market distortion, healthcare investing & culture | E1693

Episode Summary

Executive Summary: Threshold co-founder Emily Melton reflects on a career spanning multiple venture cycles and explains why her firm prioritizes focused, hands-on early-stage investing. She argues healthcare—especially women’s healthcare—is both a major investment opportunity and a social necessity. In the current downturn, founders and investors must adapt to tighter capital, build sustainable companies, and stay aligned around the hard work of creating enduring businesses.

Main Topics: Learning through venture downturns: Melton began in venture at Tim Draper’s firm around 1999 and entered the 2000–01 downturn soon after. Her early work included helping struggling companies wind down, which taught her the financial and psychological dimensions of a market correction. Threshold’s focused, hands-on model: Melton and her partners founded Threshold to concentrate on early company-building, with small portfolios and substantial involvement. She describes the firm as the mechanic that helps build a company’s engine, rather than the source of later growth capital. Healthcare and women’s health: Melton sees healthcare’s inefficiency and cost as both an urgent societal problem and a large market opportunity. She emphasizes holistic care, better access, and solutions designed around women’s needs, citing Tia as an example of a patient-centered model. Culture, diversity, and investment decisions: Threshold aims for a diverse team, transparent decision-making, and constructive disagreement rather than consensus or deal-trading. Melton says a strong partnership examines risks carefully, commits to decisions, and shares responsibility across the portfolio. Adapting to a changed financing environment: Melton distinguishes familiar downturn dynamics from newer conditions, including higher interest rates, less favorable globalization trends, and technology becoming table stakes. She urges companies to assess customer and business risks, conserve resources, and pursue sustainable growth. Founder motivation and secondary sales: Large founder secondary sales during the recent boom may weaken incentives to remain involved, while inflated valuations can leave other founders working hard just to regain prior value. Melton argues that enduring companies require founders driven by a durable purpose, not an expectation of an easy path to wealth.

Key Arguments: Experience in downturns helps investors understand that corrections are not only financial events but also psychologically difficult transitions; empathy and practical guidance matter. A concentrated early-stage firm can add value through company-building—such as leadership changes and go-to-market development—while remaining an independent, credible advocate when companies seek later-stage investors. Healthcare innovation is both a financial opportunity and a necessity because costs and inefficiencies impose substantial burdens. Solutions should address people and interconnected health needs rather than isolated symptoms. Women’s healthcare has been underserved despite women representing a large share of the population and medical spending. Better clinical understanding and respectful, convenient care can address unmet needs. Venture firms need clear incentives, transparency, and room for informed disagreement. Risk-taking is appropriate when the potential upside justifies the risk, even though some bets will fail. Companies should respond to the current market by focusing on survival, profitability, and genuine leverage rather than relying on abundant capital. Boards and investors share responsibility for earlier plans and should help founders reset without shaming them. Founder secondary liquidity can be reasonable in some circumstances, but exceptionally large sales may reduce a founder’s motivation to continue building; alignment between founders and their companies remains essential.

Data Points: Threshold current fund size: $375 million - Melton described the size of Threshold’s current fund. Typical initial investment: $5–6 million to $12–15 million - Threshold’s usual check size varies with the company’s stage and needs. Target portfolio size: 25–30 positions - The concentrated portfolio reflects the firm’s board-level involvement and finite time. Investment pace: About 1–2 investments per quarter - Melton described the pace of new investments given the firm’s hands-on model. Women’s share of the population: 51% - Melton used this figure to emphasize the scale of the women’s healthcare market. Women’s share of medical spending: 80% - Melton cited this figure while discussing the mismatch between women’s healthcare needs and tailored solutions. Women’s participation in clinical trials: Women were not considered in most clinical trials until the 1990s - Melton highlighted the historical lack of representation in medical research. Career start and market downturn: Graduated in 1999; joined venture shortly before the 2000–01 correction - Melton’s early career exposed her to a major downturn and company wind-downs.

Pivotal Quotes: "The mechanic isn't sexy, but it's required because if you pour gas in an engine that isn't well built, you're not going to go anywhere." — Emily Melton: She explains why Threshold prioritizes hands-on company-building before later-stage growth capital. "You got to be present to win." — Emily Melton: She emphasizes that companies must survive the near term to benefit from long-term market trends. "The why doesn't change. The what can evolve over time." — Emily Melton: She describes the durable motivation she believes founders need to endure a difficult entrepreneurial journey.

Implications: Founders should plan for durable businesses, reassess risks, and align teams around realistic goals. Investors can add value through focused support and candid partnership. Healthcare, particularly women’s health, remains a large opportunity where better-designed care could deliver both financial and societal returns.